A Study of HS-20137 in Participants with Moderate-to-severe Plaque Psoriasis

NCT06844799 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

720

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate-to-severe Plaque Psoriasis

Interventions

DRUG: HS-20137
DRUG: Placebo&HS-20137

Sponsor

Hansoh BioMedical R&D Company